Market Overview
Cancer is a type of chronic disease in which cell in the body witness abnormal and uncontrolled growth, resulting in the formation of a mass known as tumor, which is cancerous or benign in nature. Head and neck cancer is referred for various malignant tumors developed around nose, throat, larynx, sinuses, and mouth. Furthermore, this type of cancer can develop in squamous cells, which line moist surfaces such as mouth, nose, and throat. Furthermore, salivary glands contain different types of cells that can turn cancerous. The primary risk factors for head and neck cancer are excessive alcohol consumption, chewing tobacco, infection with human papillomavirus (HPV), etc. Other risk factors include excessive consumption of paan (betel quid), preserved or salted foods, oral health, occupational exposure, radiation exposure, Epstein barr virus infection, and due to hereditary causes.
Market Drivers
Increasing cases of head and neck cancer is expected to drive growth of the global head and neck cancer market during the forecast period. According to National Center for Biotechnology Information, head and neck cancer is the sixth-most common cancer worldwide, with around 630,000 new patients diagnosed every year, in turn resulting in over 350,000 deaths. Symptoms include a change or hoarseness in the voice, a lump or sore that does not heal, sore throat that does not go away, and unexplained and prolonged trouble swallowing. Around 75% of head and neck cancers are...
Read Full Story: https://www.medgadget.com/2021/11/actionable-insights-on-head-and-neck-cancer-market-by-type-application-regions-with-in-detailed-competitor-analysis-ab-science-sa-bayer-ag-bristol-myers-squibb-company.html
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.
